Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Q3 Results

<< Previous

Bullboard Posts

Next >>

Comment by Starkickeron Nov 05, 2024 10:05am

85 Views

Post# 36296919

RE:Q3 Results

Gross margin looks about right. Based on forward looking comments from management last three reporting sessions and upward trends in jurisdictions you mentioned (though I believe the CDN market picked up a bit in 2024) I'll be disappointed if Q3 revenue is below $13M.

<< Previous

Bullboard Posts

Next >>

Crypto and blockchain stock ends year with a profit